General Surgery Resident PhysicianDivision of Vascular Surgery and Endovascular Therapy, Department of Surgery, The Johns Hopkins School of Medicine, Baltimore, MD
VESS16 - Trends in Rivaroxaban Use for Symptomatic Peripheral Artery Disease Before and After FDA Approval
Wednesday, June 10, 20263:57 PM - 4:05 PM ET